Literature DB >> 8783505

Mechanism of action of cholera toxin & other toxins.

N K Ganguly1, T Kaur.   

Abstract

Vibrio cholerae produce a variety of extracellular products that have deleterious effects on eukaryotic cells. The massive diarrhoea produced by V. cholerae is caused by cholera toxin (CT). CT is composed of 1A and 5B units. CT causes a significant amount of fluid secretion and haemorrhage in the ligated rabbit ileal loops. Its action involves the role of various biochemical pathways. CT acts by activation of adenylate cyclase-cAMP system located at the basolateral membrane of intestinal epithelial cells. The increase in cyclic AMP levels is mainly responsible for the altered transport of Na+ and Cl-. Besides activating cAMP, CT is also known to act through release of prostaglandins and involvement of intramural nerves. Besides CT, other bacterial toxins like Escherichia coli LT, Salmonella toxin, Shigella toxin and Campylobacter toxin also possess A-B structure. The structure and function of E. coli LT resembles closely that of CT. Most of the bacterial toxins exert their effect through involvement of ADP-ribosylating proteins whereas other toxins involve guanylate cyclase system, calcium and protein kinases for their ultimate action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8783505

Source DB:  PubMed          Journal:  Indian J Med Res        ISSN: 0971-5916            Impact factor:   2.375


  18 in total

1.  Central sensitization in the trigeminal nucleus caudalis produced by a conjugate of substance P and the A subunit of cholera toxin.

Authors:  Robert M Caudle; Christopher King; Todd A Nolan; Shelby K Suckow; Charles J Vierck; John K Neubert
Journal:  J Pain       Date:  2010-09       Impact factor: 5.820

2.  Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts.

Authors:  C K Ho; H J Peng; S Y Wang
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

3.  Antileishmanial Activity of Lignans, Neolignans, and Other Plant Phenols.

Authors:  Jiří Pospíšil; Daniela Konrádová; Miroslav Strnad
Journal:  Prog Chem Org Nat Prod       Date:  2021

4.  Studies on Pongamia pinnata (L.) Pierre leaves: understanding the mechanism(s) of action in infectious diarrhea.

Authors:  S Brijesh; P G Daswani; P Tetali; S R Rojatkar; N H Antia; T J Birdi
Journal:  J Zhejiang Univ Sci B       Date:  2006-08       Impact factor: 3.066

5.  Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer.

Authors:  Muthusamy Thangaraju; Gail Cresci; Shiro Itagaki; John Mellinger; Darren D Browning; Franklin G Berger; Puttur D Prasad; Vadivel Ganapathy
Journal:  J Gastrointest Surg       Date:  2008-07-26       Impact factor: 3.452

Review 6.  Staying Alive: Vibrio cholerae's Cycle of Environmental Survival, Transmission, and Dissemination.

Authors:  Jenna G Conner; Jennifer K Teschler; Christopher J Jones; Fitnat H Yildiz
Journal:  Microbiol Spectr       Date:  2016-04

Review 7.  Modulation of gut physiology through enteric toxins.

Authors:  Tanvir Kaur; Nirmal Kumar Ganguly
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

8.  Colonic gene expression in conventional and germ-free mice with a focus on the butyrate receptor GPR109A and the butyrate transporter SLC5A8.

Authors:  Gail A Cresci; Muthusamy Thangaraju; John D Mellinger; Kebin Liu; Vadivel Ganapathy
Journal:  J Gastrointest Surg       Date:  2009-12-22       Impact factor: 3.452

9.  Studies on the antidiarrhoeal activity of Aegle marmelos unripe fruit: validating its traditional usage.

Authors:  S Brijesh; Poonam Daswani; Pundarikakshudu Tetali; Noshir Antia; Tannaz Birdi
Journal:  BMC Complement Altern Med       Date:  2009-11-23       Impact factor: 3.659

10.  Bile and unsaturated fatty acids inhibit the binding of cholera toxin and Escherichia coli heat-labile enterotoxin to GM1 receptor.

Authors:  Arpita Chatterjee; Rukhsana Chowdhury
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.